MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
COCH — Envoy Medical, Inc. Class A Common Stock
NasdaqEnvoy Medical, Inc. Class A Common Stock
$0.68
+0.02(+2.63%)
- O
- 0.68
- H
- 0.70
- L
- 0.65
- V
- 160.58K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About COCH
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
IndustryORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
SectorNot available
IPO DateOct 2, 2023
Employees47
Stock ExchangeNasdaq
Ticker SymbolCOCH
Websitehttps://www.envoymedical.com
Key Financial Statistics
| Market Cap | $52.47M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.36 - $1.89 |
| 52-Week Avg Volume | 1.06M |
| VWAP | $0.67 |
| Transactions | 409 |
| Total Recorded Bars | 755 days |